Cost-Effectiveness of Evolocumab in Patients with High Cardiovascular Risk in Spain
Abstract
Authors
G Villa M Lothgren L Kutikova P Lindgren SR Gandra GC Fonarow F Sorio L Masana A Bayes-Genis B van Hout
G Villa M Lothgren L Kutikova P Lindgren SR Gandra GC Fonarow F Sorio L Masana A Bayes-Genis B van Hout
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now